UK markets open in 4 minutes

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4900-0.1600 (-6.04%)
At close: 04:00PM EDT
2.2800 -0.21 (-8.43%)
After hours: 07:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-4.56-3.44-13.38-24.37
Low estimate-4.56-3.44-13.38-24.37
High estimate-4.56-3.44-13.38-24.37
Year ago EPS-7.05-6.6-26.75-13.38
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/A373k420kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-9.95-7.55-5.45-5.89
Actual EPS-7.05-6.6-7.35-6.23
Difference2.90.95-1.9-0.34
Surprise %29.10%12.60%-34.90%-5.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-4.56-3.44-13.38-24.37
7 days ago-4.56-3.44-13.38-24.37
30 days ago-4.56-3.44-13.38-24.37
60 days ago-5.92-5.98-15.67-24.37
90 days ago-5.92-5.98-15.67-24.37
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCYCCIndustrySector(s)S&P 500
Current qtr.35.30%N/AN/AN/A
Next qtr.47.90%N/AN/AN/A
Current year50.00%N/AN/AN/A
Next year-82.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A